These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15886422

  • 1. Synthesis and 5-HT1A/5-HT2A activity of some butyl analogs in the group of phenylpiperazine alkyl pyrimido[2,1-f]theophyllines.
    Kołaczkowski M, Zajdel P, Fhid O, Duszyńska B, Tatarczyńska E, Pawłowski M.
    Pharmacol Rep; 2005; 57(2):229-35. PubMed ID: 15886422
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [Abstract] [Full Text] [Related]

  • 5. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
    Zajdel P, Subra G, Bojarski AJ, Duszyńska B, Tatarczyńska E, Nikiforuk A, Chojnacka-Wójcik E, Pawłowski M, Martinez J.
    Bioorg Med Chem; 2007 Apr 15; 15(8):2907-19. PubMed ID: 17321139
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
    Boksa J, Charakchieva-Minol S, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Bojarski AJ.
    Pol J Pharmacol; 2003 Apr 15; 55(6):1013-9. PubMed ID: 14730096
    [Abstract] [Full Text] [Related]

  • 7. Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands.
    Byrtus H, Pawłowski M, Duszyńska B, Wesołowska A, Chojnacka-Wójcik E, Bojarski AJ.
    Pol J Pharmacol; 2001 Apr 15; 53(4):395-401. PubMed ID: 11990087
    [Abstract] [Full Text] [Related]

  • 8. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J, Mokrosz MJ, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Wesołowska A, Misztal S.
    Pol J Pharmacol; 2001 Apr 15; 53(5):501-8. PubMed ID: 11990069
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
    Obniska J, Tatarczyńska E, Nikiforuk A, Charakchieva-Minol S, Duszyńska B.
    Pharmacol Rep; 2006 Apr 15; 58(1):107-14. PubMed ID: 16531637
    [Abstract] [Full Text] [Related]

  • 10. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ, Boksa J, Charakchieva-Minol S, Wesołowska A, Borycz J.
    Pol J Pharmacol; 1999 Apr 15; 51(4):351-6. PubMed ID: 10540967
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
    Obniska J, Pawłowski M, Kołaczkowski M, Czopek A, Duszyńska B, Klodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Apr 15; 55(4):553-7. PubMed ID: 14581713
    [Abstract] [Full Text] [Related]

  • 12. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A.
    Pol J Pharmacol; 1999 Apr 15; 51(5):415-21. PubMed ID: 10817542
    [Abstract] [Full Text] [Related]

  • 13. Interaction of 1,2,4-substituted piperazines, new serotonin receptor ligands, with 5-HT1A and 5-HT2A receptors.
    Chilmonczyk Z, Cybulski M, Iskra-Jopa J, Chojnacka-Wójcik E, Tatarczyńska E, Kłodzińska A, Leś A, Bronowska A, Sylte I.
    Farmaco; 2002 Apr 15; 57(4):285-301. PubMed ID: 11989808
    [Abstract] [Full Text] [Related]

  • 14. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D.
    J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407
    [Abstract] [Full Text] [Related]

  • 15. Effect of linking bridge modifications on the 5-HT1A receptor activity of some 4-(omega-benzotriazol-1-yl)alkyl-1-(2-methoxy-phenyl)piperazines.
    Paluchowska MH, Kłodzińska A, Tatarczyńska E, Szaro A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998 May 06; 50(4-5):341-7. PubMed ID: 10091719
    [Abstract] [Full Text] [Related]

  • 16. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998 May 06; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

  • 17. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Bojarski AJ, Wesołowska A.
    Pol J Pharmacol; 2001 May 06; 53(4):369-76. PubMed ID: 11990083
    [Abstract] [Full Text] [Related]

  • 18. Structure-activity relationship studies of CNS agents. Part 38. Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Bojarski AJ, Fruziński A, Karolak-Wojciechowska J, Wesołowska A, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Arch Pharm (Weinheim); 1999 Nov 06; 332(11):373-9. PubMed ID: 10605377
    [Abstract] [Full Text] [Related]

  • 19. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J, Klodzińska A, Charakchieva-Minol S, Chojnacka-Wójcik E, Mokrosz JL.
    Pharmazie; 1996 Feb 06; 51(2):72-6. PubMed ID: 8720802
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1.
    Wróbel MZ, Chodkowski A, Herold F, Gomółka A, Kleps J, Mazurek AP, Pluciński F, Mazurek A, Nowak G, Siwek A, Stachowicz K, Sławińska A, Wolak M, Szewczyk B, Satała G, Bojarski AJ, Turło J.
    Eur J Med Chem; 2013 May 06; 63():484-500. PubMed ID: 23524160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.